Jean-Francois Morineau
Direttore operativo presso BNP Paribas Real Estate Conseil Habitation & Hospitality SAS
Posizioni attive di Jean-Francois Morineau
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
BNP Paribas Real Estate Conseil Habitation & Hospitality SAS
 BNP Paribas Real Estate Conseil Habitation & Hospitality SAS Real Estate DevelopmentFinance Part of BNP Paribas SA, BNP Paribas Real Estate Conseil Habitation & Hospitality SAS operates as a real estate agency. The company is based in Issy-Les-Moulineaux, France. | Direttore operativo | 11/05/2011 | - |
Egle Therapeutics SAS
 Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Jean-Francois Morineau
Statistiche
Distribuzione geografica
| Francia | 3 |
Posizioni
| Chief Operating Officer | 1 |
| Director/Board Member | 1 |
Settori
| Finance | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
BNP Paribas Real Estate Conseil Habitation & Hospitality SAS
BNP Paribas Real Estate Conseil Habitation & Hospitality SAS Real Estate DevelopmentFinance Part of BNP Paribas SA, BNP Paribas Real Estate Conseil Habitation & Hospitality SAS operates as a real estate agency. The company is based in Issy-Les-Moulineaux, France. | Finance |
Egle Therapeutics SAS
Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Commercial Services |
